News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT) 2Q Profit Beats Expectations as Humira Sales Grow



7/18/2012 10:04:19 AM

Abbott Laboratories on Wednesday said second-quarter earnings narrowly beat analysts' estimates despite a strengthening dollar that carved out value from the company's overseas sales. The North Chicago-based healthcare company said net income for the quarter declined 11 percent to $1.75 billion, or $1.08 a share, as unfavorable foreign currency exchange rates and charges related to its planned split up offset modest sales gains. Excluding the special charges, profits jumped 11.2 percent to $1.97 billion, or $1.23 per share.

Read at Chicago Tribune
Read at PharmaBiz
Read at RTT News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES